Skip to main content
Retour
Watch Compare

Neuphoria Therapeutics Inc.

Qualité des données : 100%
NEUP
Nasdaq Manufacturing Chemicals
4,61 €
▼ 0,09 € (-1,91%)
Cap. Boursière: 24,85 M
Prix
4,61 €
Cap. Boursière
24,85 M
Fourchette du Jour
4,57 € — 4,73 €
Fourchette 52 Semaines
3,65 € — 21,40 €
Volume
41 265
Ouverture 4,73 €
Moyenne 50J / 200J
4,28 €
7,71% above
Moyenne 50J / 200J
6,87 €
32,86% below

Quick Summary

Points Clés

Generating 77 229,0 in free cash flow

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-1,33%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC-2,82%
Net Margin-2,36%
Op. Margin-7,21%

Sécurité

Debt / Equity
N/A
Current Ratio11,01
Interest CoverageN/A

Valorisation

PE (TTM)
-67,23
En dessous de la moyenne du secteur (-1,48)
P/B Ratio0,96
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -67,2 -1,5
P/B 1,0 1,6
ROE % -1,3 -53,4
Net Margin % -2,4 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
4,03% weight
BRUSX BRUSX
0,06% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 15,65 M Net Income (TTM) -369 632,0
ROE -1,33% ROA -1,10%
Gross Margin N/A Operating Margin -7,21%
Net Margin -2,36% Free Cash Flow (TTM) 77 229,0
ROIC -2,82% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 11,01
Interest Coverage N/A Asset Turnover 0,47
Working Capital 15,54 M Tangible Book Value 12,58 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -67,23 Forward P/E N/A
P/B Ratio 0,96 P/S Ratio 1,59
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,31%
Market Cap 24,85 M Enterprise Value 7,81 M
Per Share
EPS (Diluted TTM) -0,23 Revenue / Share 2,90
FCF / Share 0,01 OCF / Share 0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -20,89%
SBC-Adj. FCF -86 543 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 15,65 M —
Net Income -369 632,0 -15,49 M
EPS (Diluted) -0,23 -0,01
Gross Profit — —
Operating Income -1,13 M -17,89 M
EBITDA — —
R&D Expenses 9,01 M 9,42 M
SG&A Expenses — —
D&A 662 890,0 662 991,0
Interest Expense — —
Income Tax -468 366,0 -87 320,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 28,59 M 27,65 M
Total Liabilities 9,59 M 10,16 M
Shareholders' Equity 19,00 M 17,49 M
Total Debt — —
Cash & Equivalents 14,21 M 12,61 M
Current Assets 15,04 M 13,19 M
Current Liabilities 4,22 M 3,83 M